Baliopharm's Acquisition - II

Baliopharm raised a round of funding on April 10, 2018. Investors include Promethera Biosciences.

Baliopharm is a biotechnology company focusing on the development of biosimilar therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple…

Articles about Baliopharm's Acquisition - II: